Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BARX homeobox 1 (BARX1) is a DNA-binding transcription factor belonging to the Bar subclass of homeobox proteins. It plays a critical role during embryonic development, particularly in the formation of craniofacial structures, tooth development, and the differentiation of stomach epithelia. BARX1 functions as a transcriptional regulator, modulating gene expression involved in mesenchymal proliferation and organogenesis. It is primarily expressed in tissues undergoing morphogenesis, especially where neural crest-derived mesenchyme is present. Mutations or alterations in BARX1 have been associated with congenital anomalies such as pyloric stenosis and jaw fusion disorders, but it is not currently considered a therapeutic target for pharmacological intervention.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BARX homeobox 1 (BARX1).